Katharina A. Schindlbeck, MD is a clinician-scientist from Germany interested in movement disorders. She pursued her residency program in neurology at the Charité in Berlin, which for the past decade has ranked as the best of over 1,000 hospitals in Germany. Dr. Schindlbeck furthered her clinical training in a specialized outpatient clinic for movement disorders, and also gained neuroradiology training in magnetic resonance imaging techniques to study biomarkers. Her research focused on the non-motor aspects of Parkinson’s disease, particularly on sensory and cognitive symptoms and how they affect the motor dysfunction and overall disease burden. To deepen her scientific training and to learn the most rigorous approaches to functional imaging analysis, Dr. Schindlbeck joined the Center for Neurosciences at the Feinstein Institutes for Medical Research in 2016 on a Leopoldina Postdoc Scholarship to study genotypic influences on cognitive impairment in Parkinson’s disease using network-based functional imaging methods (especially PET, but also fMRI). As a co-investigator on a grant award from the Michael J. Fox foundation, Dr. Schindlbeck is studying the role of genotypic influences on Parkinson’s disease progression at the network level.